Seek Returns logo

ALNY vs. NVO: A Head-to-Head Stock Comparison

Updated

Here’s a clear look at ALNY and NVO, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.

Company Overview

NVO stands out with 305.18 billion USD in market value—about 8.00× ALNY’s market cap of 38.15 billion USD.

With betas of 0.17 for ALNY and 0.21 for NVO, both show similar volatility profiles relative to the overall market.

NVO is an ADR, letting U.S. buyers tap its non-U.S. business directly, unlike ALNY, which is purely domestic.

SymbolALNYNVO
Company NameAlnylam Pharmaceuticals, Inc.Novo Nordisk A/S
CountryUSDK
SectorHealthcareHealthcare
IndustryBiotechnologyDrug Manufacturers - General
CEODr. Yvonne L. Greenstreet M.B.A., M.D.Mr. Lars Fruergaard Jorgensen
Price292.58 USD68.2 USD
Market Cap38.15 billion USD305.18 billion USD
Beta0.170.21
ExchangeNASDAQNYSE
IPO DateJune 1, 2004April 30, 1981
ADRNoYes

Performance Comparison

This chart compares the performance of ALNY and NVO over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Hover over the lines to see the investment’s value and total return (%) at specific dates.

Data is adjusted for dividends and splits.

Valuation Metrics Comparison

The section examines key financial ratios to assess the valuation of ALNY and NVO based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.

  • ALNY posts a negative P/E of -140.68, reflecting last year’s net loss, while NVO at 18.78 signals healthy earnings.
  • ALNY posts a negative forward PEG of -38.16, hinting at anticipated earnings decline, whereas NVO at 1.31 has projections for stable or growing earnings.
  • ALNY has a negative Price-to-Free Cash Flow ratio of -506.05, signaling it consumed more cash than it produced over the last year—an important liquidity warning. In contrast, NVO (P/FCF 26.50) indicates positive free cash flow generation.
SymbolALNYNVO
Price-to-Earnings Ratio (P/E, TTM)-140.6818.78
Forward PEG Ratio (TTM)-38.161.31
Price-to-Sales Ratio (P/S, TTM)16.256.53
Price-to-Book Ratio (P/B, TTM)328.6814.18
Price-to-Free Cash Flow Ratio (P/FCF, TTM)-506.0526.50
EV-to-EBITDA (TTM)-251.7312.81
EV-to-Sales (TTM)16.376.80
EV-to-Free Cash Flow (TTM)-509.8027.57

Dividend Comparison

ALNY offers a 0% dividend yield, suggesting it may be reinvesting available cash back into the business for future growth, while NVO provides a 2.58% dividend yield, giving investors a steady income stream.

SymbolALNYNVO
Dividend Yield (TTM)0.00%2.58%

Financial Strength Metrics Comparison

This section dives into the financial resilience of ALNY and NVO, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.

  • NVO’s current ratio of 0.74 indicates its assets may not cover near-term debts, whereas ALNY at 3.04 maintains healthy liquidity.
  • NVO posts a quick ratio of 0.56, indicating limited coverage of short-term debts from its most liquid assets—while ALNY at 2.98 enjoys stronger liquidity resilience.
  • ALNY is heavily leveraged (debt-to-equity ratio 11.28), which can boost returns but raises risk if borrowing costs climb, while NVO at 0.86 keeps leverage at a more moderate level.
  • With negative EBIT (-0.79), ALNY cannot cover its interest payments. NVO, with an interest coverage of 17.84, meets its interest obligations.
SymbolALNYNVO
Current Ratio (TTM)3.040.74
Quick Ratio (TTM)2.980.56
Debt-to-Equity Ratio (TTM)11.280.86
Debt-to-Assets Ratio (TTM)0.310.24
Interest Coverage Ratio (TTM)-0.7917.84